United States· US:51672-5263_4cd6638c-db25-e28b-e063-6294a90a4a9a
Topicort
A medicinal product containing desoximetasone, registered in United States by Sun Pharmaceutical Industries, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DESOXIMETASONE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1151672-5263-5
- ndc1151672-5263-7
- ndc1151672526311 TUBE in 1 CARTON (51672-5263-1) / 15 g in 1 TUBE
- ndc1151672526321 TUBE in 1 CARTON (51672-5263-2) / 30 g in 1 TUBE
- ndc11516725263510 TUBE in 1 CARTON (51672-5263-5) / 5 g in 1 TUBE
- ndc1151672526371 TUBE in 1 CARTON (51672-5263-7) / 100 g in 1 TUBE
- ndc1151672-5263-1
- ndc1151672-5263-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Desoximetasone in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaTOPICORTBAUSCH HEALTH, CANADA INC.
- FinlandIbarilSanofi Oy
- NetherlandsDesoximetason Bipharma 2,5 mg/g, hydrofobe crèmeBipharma B.V.
- NorwayDesoximetason bipharmaBipharma
- United KingdomStiedex LP 0.05% oily creamStiefel Laboratories (UK) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Italy · Flubason
- Netherlands · Desoximetason Bipharma, Topicorte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0e5a1d4-32b1-4e37-8a64-6b8c7eef71c2 GET /v1/drugs/b0e5a1d4-32b1-4e37-8a64-6b8c7eef71c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".5",
"substance": "DESOXIMETASONE",
"productndc": "51672-5263",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "NDA018594",
"marketing_category": "NDA"
}See everything about desoximetasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.